Patients Dramatically Reduce Their Opioid Use Following Cannabis Access

MMJ reduces opioid use

CANADA: Pain patients enrolled in Canada’s legal medical cannabis access program significantly reduce their use of opioids over the long-term, according to longitudinal data provided by Tilray Canada Ltd - one of the nation’s largest, licensed provider of medicinal marijuana products. Investigators assessed opioid use patterns in a cohort of 573 patients using Tilray-provided products. Among those patients who acknowledged Read the full article…